[Evaluation of clinical effectiveness of the use of enterosorbent enterosgel in patients with diabetes mellitus and suppurative-inflammatory lesions of soft tissues].
While complex application of "Enterosgel" preparation in 47 patients with diabetes mellitus the acceleration of disease compensation was noted, what permitted to lower the sugar-reducing preparations dosage. This correspondingly improved the cholesterol indexes in blood plasma, what have illustrated the detoxication processes in organism and softening of purulent-inflammatory processes.